Survival from hepatocellular carcinoma at a cancer hospital in Pakistan

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 2, 2007, Pages 272-274

  Yusuf, Muhammed Aasim ^a   Badar, Farhana ^a   Meerza, Fouzia ^a   Khokhar, Rizwan Anwar ^a   Ali, Faiqa A ^a   Sarwar, Shahbaz ^a   Faruqui, Zia Salman ^a  

^a SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

Author keywords

Hepatocellular carcinoma; Pakistan; Patient characteristics; Survival

Indexed keywords

ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PAKISTAN; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; SURVIVOR; TIME;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PAKISTAN; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 40449125934     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Abbas Z, Hassan SM, Aziz S, et al (2002). Prospects of liver transplantation in Pakistan-Review. Transplant Proc, 34, 2472.
2. American Cancer Society: Cancer Facts and Figures (2006). Atlanta, Ga: American Cancer Society.
3. Bhurgri Y (2004). Karachi Cancer Registry Data - implications for the National Cancer Control Program of Pakistan. Asian Pac J Cancer Prev, 5, 77-82.
4. Bukhtiari N, Hussain T, Iqbal M, et al (2003). Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc, 53, 136-40.
5. Haider Z, Ul Haq T, Munir K, et al (2006). Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma. J Coll Physicians Surg Pak, 16, 265-9.
6. Khokhar N, Aijazi I, Gill ML (2003). Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad. J Ayub Med Coll Abbottabad, 15, 1-4.
7. Llovet JM, Fuster J, Bruix J (2002). Prognosis of hepatocellular carcinoma. Hepatogastroenterology, 49, 7-11.
8. Mujeeb S, Jamal Q, Khanani R, et al (1997). Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan. Trop Doct, 27, 45-6.